Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-12 Purchase |
2025-02-12 8:09 pm |
ENANTA PHARMACEUTICALS INC | ENTA | Luly Jay R. President and CEO |
45,000 | $5.69 | $256,050 | 846,638 (Direct) |
View |
| 2024-12-06 Sale |
2024-12-10 5:12 pm |
ENANTA PHARMACEUTICALS INC | ENTA | Kieffer Tara Lynn Chief Product Strategy Officer |
2,283 | $8.06 | $18,401 | 29,305 (Direct) |
View |
| 2024-12-06 Sale |
2024-12-10 5:08 pm |
ENANTA PHARMACEUTICALS INC | ENTA | Luu Brendan Chief Business Officer |
2,283 | $8.06 | $18,401 | 36,047 (Direct) |
View |
| 2024-12-06 Sale |
2024-12-10 5:03 pm |
ENANTA PHARMACEUTICALS INC | ENTA | Rottinghaus Scott T. Chief Medical Officer |
866 | $8.06 | $6,980 | 17,918 (Direct) |
View |
| 2024-12-06 Sale |
2024-12-10 5:00 pm |
ENANTA PHARMACEUTICALS INC | ENTA | Or Yat Sun Chief Scientific Officer |
2,591 | $8.06 | $20,883 | 369,109 (Direct) |
View |
| 2024-12-06 Sale |
2024-12-10 4:58 pm |
ENANTA PHARMACEUTICALS INC | ENTA | MELLETT PAUL J Chief Fin. & Admin Officer |
2,591 | $8.06 | $20,883 | 91,710 (Direct) |
View |
| 2024-12-06 Sale |
2024-12-10 4:55 pm |
ENANTA PHARMACEUTICALS INC | ENTA | Luly Jay R. President and CEO |
5,142 | $8.06 | $41,445 | 801,638 (Direct) |
View |
| 2024-07-11 Sale |
2024-07-15 5:29 pm |
ENANTA PHARMACEUTICALS INC | ENTA | Rottinghaus Scott T. Chief Medical Officer |
11,945 | $15.97 | $190,747 | 102,342 (Direct) |
View |
| 2024-06-17 Sale |
2024-06-17 8:38 pm |
ENANTA PHARMACEUTICALS INC | ENTA | Kieffer Tara Lynn Chief Product Strategy Officer |
7,266 | $12.33 | $89,590 | 32,341 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-13 Option Award |
2025-03-14 5:44 pm |
N/A 2035-03-13 |
ENANTA PHARMACEUTICALS INC | ENTA | Vance Terry Director |
15,700 | $0 | 15,700 (Direct) |
View |
| 2025-03-13 Option Award |
2025-03-14 5:43 pm |
N/A 2035-03-13 |
ENANTA PHARMACEUTICALS INC | ENTA | Russell Lesley Director |
15,700 | $0 | 15,700 (Direct) |
View |
| 2025-03-13 Option Award |
2025-03-14 5:43 pm |
N/A 2035-03-13 |
ENANTA PHARMACEUTICALS INC | ENTA | Peterson Kristine Director |
15,700 | $0 | 15,700 (Direct) |
View |
| 2025-03-13 Option Award |
2025-03-14 5:35 pm |
N/A 2035-03-13 |
ENANTA PHARMACEUTICALS INC | ENTA | Hata Yujiro S Director |
15,700 | $0 | 15,700 (Direct) |
View |
| 2025-03-13 Option Award |
2025-03-14 5:34 pm |
N/A 2035-03-13 |
ENANTA PHARMACEUTICALS INC | ENTA | FOLETTA MARK G Director |
15,700 | $0 | 15,700 (Direct) |
View |
| 2025-03-13 Option Award |
2025-03-14 5:33 pm |
N/A 2035-03-13 |
ENANTA PHARMACEUTICALS INC | ENTA | CARTER BRUCE L A Director |
15,700 | $0 | 15,700 (Direct) |
View |
| 2025-02-12 Tax Withholding |
2025-02-14 4:46 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | Luu Brendan Chief Business Officer |
3,326 | $5.59 | 40,221 (Direct) |
View |
| 2025-02-12 Option Award |
2025-02-14 4:46 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | Luu Brendan Chief Business Officer |
7,500 | $0 | 40,221 (Direct) |
View |
| 2025-02-12 Tax Withholding |
2025-02-14 4:44 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | Kieffer Tara Lynn Chief Product Strategy Officer |
3,326 | $5.59 | 33,479 (Direct) |
View |
| 2025-02-12 Option Award |
2025-02-14 4:44 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | Kieffer Tara Lynn Chief Product Strategy Officer |
7,500 | $0 | 33,479 (Direct) |
View |
| 2025-02-12 Tax Withholding |
2025-02-14 4:42 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | Rottinghaus Scott T. Chief Medical Officer |
2,861 | $5.59 | 24,807 (Direct) |
View |
| 2025-02-12 Option Award |
2025-02-14 4:42 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | Rottinghaus Scott T. Chief Medical Officer |
9,750 | $0 | 24,807 (Direct) |
View |
| 2025-02-12 Tax Withholding |
2025-02-14 4:40 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | Or Yat Sun Chief Scientific Officer |
4,324 | $5.59 | 374,535 (Direct) |
View |
| 2025-02-12 Option Award |
2025-02-14 4:40 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | Or Yat Sun Chief Scientific Officer |
9,750 | $0 | 374,535 (Direct) |
View |
| 2025-02-12 Tax Withholding |
2025-02-14 4:37 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | MELLETT PAUL J Chief Fin. & Admin Officer |
3,326 | $5.59 | 95,884 (Direct) |
View |
| 2025-02-12 Option Award |
2025-02-14 4:37 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | MELLETT PAUL J Chief Fin. & Admin Officer |
7,500 | $0 | 95,884 (Direct) |
View |
| 2025-02-12 Tax Withholding |
2025-02-14 4:35 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | Luly Jay R. President and CEO |
7,484 | $5.59 | 864,654 (Direct) |
View |
| 2025-02-12 Option Award |
2025-02-14 4:35 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | Luly Jay R. President and CEO |
25,500 | $0 | 864,654 (Direct) |
View |
| 2024-12-01 Tax Withholding |
2024-12-03 6:41 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | Luu Brendan Chief Business Officer |
753 | $8.6 | 38,330 (Direct) |
View |
| 2024-12-01 Tax Withholding |
2024-12-03 6:37 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | Kieffer Tara Lynn Chief Product Strategy Officer |
753 | $8.6 | 31,588 (Direct) |
View |
| 2024-12-01 Tax Withholding |
2024-12-03 6:35 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | Or Yat Sun Chief Scientific Officer |
1,595 | $8.6 | 371,700 (Direct) |
View |
| 2024-12-01 Tax Withholding |
2024-12-03 6:32 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | MELLETT PAUL J Chief Fin. & Admin Officer |
1,595 | $8.6 | 94,301 (Direct) |
View |
| 2024-12-01 Tax Withholding |
2024-12-03 6:28 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | Luly Jay R. President and CEO |
3,829 | $8.6 | 806,780 (Direct) |
View |
| 2024-11-27 Option Award |
2024-11-27 5:10 pm |
N/A 2034-11-27 |
ENANTA PHARMACEUTICALS INC | ENTA | Kowalsky Matthew Paul Chief Legal Officer |
75,000 | $0 | 75,000 (Direct) |
View |
| 2024-11-27 Option Award |
2024-11-27 5:08 pm |
N/A 2034-11-27 |
ENANTA PHARMACEUTICALS INC | ENTA | Luu Brendan Chief Business Officer |
75,000 | $0 | 75,000 (Direct) |
View |
| 2024-11-27 Option Award |
2024-11-27 5:06 pm |
N/A 2034-11-27 |
ENANTA PHARMACEUTICALS INC | ENTA | Kieffer Tara Lynn Chief Product Strategy Officer |
81,000 | $0 | 81,000 (Direct) |
View |
| 2024-11-27 Option Award |
2024-11-27 5:04 pm |
N/A 2034-11-27 |
ENANTA PHARMACEUTICALS INC | ENTA | Rottinghaus Scott T. Chief Medical Officer |
87,000 | $0 | 87,000 (Direct) |
View |
| 2024-11-27 Option Award |
2024-11-27 5:03 pm |
N/A 2034-11-27 |
ENANTA PHARMACEUTICALS INC | ENTA | Or Yat Sun Chief Scientific Officer |
87,000 | $0 | 87,000 (Direct) |
View |
| 2024-11-27 Option Award |
2024-11-27 5:01 pm |
N/A 2034-11-27 |
ENANTA PHARMACEUTICALS INC | ENTA | MELLETT PAUL J Chief Fin. & Admin Officer |
81,000 | $0 | 81,000 (Direct) |
View |
| 2024-11-27 Option Award |
2024-11-27 4:59 pm |
N/A 2034-11-27 |
ENANTA PHARMACEUTICALS INC | ENTA | Luly Jay R. President and CEO |
250,000 | $0 | 250,000 (Direct) |
View |
| 2023-08-08 Tax Withholding |
2024-08-09 5:24 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | Rottinghaus Scott T. Chief Medical Officer |
1,467 | $17.23 | 18,784 (Direct) |
View |
| 2024-08-08 Tax Withholding |
2024-08-09 5:24 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | Rottinghaus Scott T. Chief Medical Officer |
1,466 | $12.73 | 18,784 (Direct) |
View |
| 2024-07-15 Exercise |
2024-07-15 5:29 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | Rottinghaus Scott T. Chief Medical Officer |
5,375 | $8.99 | 102,342 (Direct) |
View |
| 2024-07-15 Exercise |
2024-07-15 5:29 pm |
N/A 2033-11-22 |
ENANTA PHARMACEUTICALS INC | ENTA | Rottinghaus Scott T. Chief Medical Officer |
5,375 | $0 | 102,342 (Direct) |
View |
| 2024-04-29 Option Award |
2024-05-01 4:27 pm |
N/A 2034-04-29 |
ENANTA PHARMACEUTICALS INC | ENTA | Kowalsky Matthew Paul Chief Legal Officer |
150,000 | $0 | 150,000 (Direct) |
View |
| 2024-03-06 Option Award |
2024-03-08 5:30 pm |
N/A 2034-03-06 |
ENANTA PHARMACEUTICALS INC | ENTA | Vance Terry Director |
15,700 | $0 | 15,700 (Direct) |
View |
| 2024-03-06 Option Award |
2024-03-08 5:27 pm |
N/A 2034-03-06 |
ENANTA PHARMACEUTICALS INC | ENTA | Russell Lesley Director |
15,700 | $0 | 15,700 (Direct) |
View |
| 2024-03-06 Option Award |
2024-03-08 5:23 pm |
N/A 2034-03-06 |
ENANTA PHARMACEUTICALS INC | ENTA | Peterson Kristine Director |
15,700 | $0 | 15,700 (Direct) |
View |
| 2024-03-06 Option Award |
2024-03-08 5:19 pm |
N/A 2034-03-06 |
ENANTA PHARMACEUTICALS INC | ENTA | Hata Yujiro S Director |
15,700 | $0 | 15,700 (Direct) |
View |